Zevra Therapeutics, Inc.
ZVRA
$8.31
$0.374.66%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -35.74M | -33.23M | -19.93M | -16.62M | -19.89M |
| Total Depreciation and Amortization | 1.65M | 1.62M | 1.56M | 1.56M | 787.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.65M | 13.71M | 694.00K | -957.00K | 5.49M |
| Change in Net Operating Assets | -4.81M | -239.00K | -1.44M | -148.00K | -2.54M |
| Cash from Operations | -16.25M | -18.14M | -19.11M | -16.17M | -16.16M |
| Capital Expenditure | -- | -- | -- | -- | -72.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -30.40M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.47M | -31.35M | -129.00K | 14.79M | 41.06M |
| Cash from Investing | -5.47M | -31.35M | -129.00K | 14.79M | 10.59M |
| Total Debt Issued | 0.00 | 0.00 | 60.07M | -- | 3.63M |
| Total Debt Repaid | 0.00 | 0.00 | -43.13M | -- | -4.73M |
| Issuance of Common Stock | 796.00K | 64.77M | 480.00K | 1.22M | 6.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -2.09M | -- | -- |
| Cash from Financing | 796.00K | 64.77M | 15.33M | 1.22M | 5.00M |
| Foreign Exchange rate Adjustments | 671.00K | -491.00K | 319.00K | -45.00K | 349.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -20.25M | 14.78M | -3.59M | -200.00K | -220.00K |
